| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0087 | 0.8 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |